Event

With the growing prominence of quality improvement, an associated emphasis has been on pay for performance. However, despite billions of dollars spent, it is unclear how efficacious these interventions are in improving care. In this session, attendees will hear from experts on innovative research regarding pay for performance: effectiveness, evidence of “gaming” and unintended consequences, and the future of incentivized health care as it pertains to ATS conditions. This is especially pertinent given ATS ownership over COPD quality measures along with the recent deployment of sepsis core measures. Attendees will learn about the recent evidence and practical implications behind these initiatives.